You have requested access to member only content.

Coronavirus fears drive medication adherence ups and downs

The cost of poor medication adherence is tremendous—nearly $177 billion each year in direct and indirect healthcare costs—but the cost of nonadherence during the COVID-19 pandemic has the potential to be much higher. Medication nonadherence can drive up otherwise avoidable hospital admissions, burdening healthcare systems already struggling to care for coronavirus patients and putting other patients at greater risk of contracting COVID-19.

This is an excerpt from members-only content. Please log in or become a member to access the full content.

Not a member? Let's fix that!

A membership to Accreditation and Quality Compliance Center provides accreditation and safety professionals with a collection of continuously updated tools, best-practice strategies, and compliance tips developed by industry experts. With two membership options, you can customize your access level depending on your education and training needs.

Register to access the free content available on the site or become a member today. Click here for more information.

For questions and support, please call customer service: 1-800-650-6787.